Pharsight

Drugs that contain Desonide

1. Verdeso patents expiration

VERDESO's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9492384 ALMIRALL Microemulsion and sub-micron emulsion process and compositions
Aug, 2025

(1 year, 6 months from now)

US8962000 ALMIRALL Microemulsion and sub-micron emulsion process and compositions
Aug, 2025

(1 year, 6 months from now)

US8460641 ALMIRALL Microemulsion process and composition
Aug, 2027

(3 years from now)

Market Authorisation Date: 19 September, 2006

Treatment: Treatment of atopic dermatitis

Dosage: AEROSOL, FOAM;TOPICAL

More Information on Dosage

VERDESO family patents

Family Patents